• Wed, February 6, 2013

by: WOPRAI

Constellation Energy Partners LLC (NYSE:CEP), Down By 8.46% ($0.11) From $1.300 After BUYINS.NET Report Predicted Stock Would G

by: WOPRAI

Measurement Specialties Inc (NASDAQ:MEAS), Down By 5.54% ($1.97) From $35.580 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

Seaspan Corp (NYSE:SSW), Down By 7.78% ($1.54) From $19.800 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearis

by: WOPRAI

Supertel Hospitality Inc (NASDAQ:SPPR), Down By 5.83% ($0.07) From $1.200 After BUYINS.NET Report Predicted Weakness Before Ear

by: WOPRAI

Neurocrine Biosciences Inc (NASDAQ:NBIX), Down By 16.77% ($1.57) From $9.360 After BUYINS.NET Report Predicted Weakness Before

by: WOPRAI

Kimco Realty Corp (NYSE:KIM), Down By 6.84% ($1.44) From $21.050 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

Excel Maritime Carriers Ltd (NYSE:EXM), Down By 17.86% ($0.10) From $0.560 After BUYINS.NET Report Predicted Weakness After Ear

by: WOPRAI

XRM SqueezeTrigger Price is $4.16. There is $1,410,711 That Short Sellers Still Need To Cover.

by: WOPRAI

AUDC SqueezeTrigger Price is $3.98. There is $485,093 That Short Sellers Still Need To Cover.

by: WOPRAI

WOOD, PBKEF, JRCC, Removed From Naked Short Lists Today

by: WOPRAI

QQEW, Has Remained On Naked Short Lists 13 Consecutive Days

by: WOPRAI

BRGO, OPHC, HNNMY, VGLT, Added To Naked Short Lists Today

by: WOPRAI

Computer Modelling Group Ltd (NYSE:CMG), Down By 7.26% ($22.70) From $312.710 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

CH Robinson Worldwide Inc (NASDAQ:CHRW), Down By 7.83% ($5.24) From $66.890 After BUYINS.NET Report Predicted Weakness After Ea

by: WOPRAI

ENSG Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

FLIC, NRF, ANTP, ENG, LTON, BDCO Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

DMND, REFR, TSYS, LPTH, JZL, JBJ Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

OPTT, DUF, LTBR, KBW, AAU, CLUB Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

WNS, ETFC Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

NSR, SPPRP, SHM, PFK, EGI, CTCM Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

ULTR, XEC, SA, SFL, MBT, WOOF Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CIDM, PDM, CDXS Expected To Be Down After Next Earnings Releases

by: WOPRAI

UEPS, GLCH, UNIS, AVNR, DCT, ESEA Expected To Be Down After Next Earnings Releases

by: WOPRAI

LCI, AHL, ATVI, ALNY, MCHP, IN Expected To Be Down After Next Earnings Releases

by: WOPRAI

AIV, SSD, RSG, LTRE, CENT, NFG Expected To Be Down After Next Earnings Releases

by: WOPRAI

ASYS, KRG, OFG, ATR, HME, CALD Expected To Be Down After Next Earnings Releases

by: WOPRAI

IMMU, MFLX, NKSH, ENH, G, ITMN Expected To Be Down After Next Earnings Releases

by: WOPRAI

MSO, JCP, ITRN, TU, ETR Expected To Be Down Before Next Earnings Releases

by: WOPRAI

VPFG, PODD, PMC, MNR Expected To Be Up After Next Earnings Releases

by: WOPRAI

CSTR, FLT, EGOV, NWPX, RGC, CFN Expected To Be Up After Next Earnings Releases

by: WOPRAI

LMIA, LOW, LINE, RRGB, TOWR, TGH Expected To Be Up Before Next Earnings Releases

by: WOPRAI

Frank Louthan Downgraded (CCOI) to Hold on, Feb 6th, 2013

by: WOPRAI

Bill Carcache Initiated (WFC) at Strong Buy and Held Target at $42 on, Feb 6th, 2013

by: WOPRAI

Joel Tiss Maintained (AGCO) at Buy with Increased Target to $63 on, Feb 6th, 2013

by: WOPRAI

Stephen Volkmann Maintained (AGCO) at Strong Buy with Increased Target to $62 on, Feb 6th, 2013

by: WOPRAI

Michael Bellisario Downgraded (AHT) to Hold on, Feb 6th, 2013

by: WOPRAI

Keith Bachman Maintained (TDC) at Hold with Increased Target to $79 on, Feb 6th, 2013

by: WOPRAI

Kevin Mcveigh Maintained (ADP) at Buy with Increased Target to $67 on, Feb 6th, 2013

by: WOPRAI

Jeffrey Silber Maintained (ADP) at Buy with Decreased Target to $65 on, Feb 6th, 2013

by: WOPRAI

Gerrick Johnson Maintained (TTWO) at Hold with Increased Target to $16 on, Feb 6th, 2013

by: WOPRAI

Andrew Uerkwitz Maintained (TTWO) at Hold with Increased Target to $13 on, Feb 6th, 2013

by: WOPRAI

William Katz Maintained (APO) at Strong Buy with Increased Target to $25 on, Feb 6th, 2013

by: WOPRAI

Alan Hellawell Upgraded (VIPS) to Strong Buy and Increased Target to $2.33 on, Feb 6th, 2013

by: WOPRAI

Bill Carcache Initiated (USB) at Strong Buy and Held Target at $38 on, Feb 6th, 2013

by: WOPRAI

John Bridges Downgraded (ACI) to Hold and Decreased Target to $70 on, Feb 6th, 2013

by: WOPRAI

George Notter Maintained (CALX) at Strong Buy with Increased Target to $11 on, Feb 6th, 2013

by: WOPRAI

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $170 on, Feb 6th, 2013

by: WOPRAI

William Katz Maintained (BX) at Strong Buy and Held Target at $24 on, Feb 6th, 2013

Andrew Peters Maintained (BIIB) at Strong Buy with Increased Target to $170 on, Feb 6th, 2013

Andrew Peters of Deutsche Bank, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $160 to $170 on, Feb 6th, 2013.

Andrew has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 3 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Decreased Target to $139 on, Thursday, January 3rd, 2013


This is the rating of the analyst that currently disagrees with Andrew

  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $175 on, Monday, October 8th, 2012

Like: 👍